Superbranche

Superbranche is a French biotechnology start-up specializing in the development of iron oxide nanoparticles with a dendrimeric coating for advanced clinical applications as cell (immuno)therapy tracers.​ ​

Using cutting-edge proprietary processes, Superbranche achieves the reproducible synthesis of superparamagnetic particles with a uniform diameter of 20 nm, an ideal size for MRI and MPI detection as well as for hyperthermia-based therapies. The dendrimer coating significantly enhances the biocompatibility of these nanoparticles, reducing toxicity while enabling efficient and long-term internalization across various cell types.​ ​

Superbranche’s nanoparticles have already been successfully tested on iPSCs, extracellular vesicles (EVs), and numerous other cell models, demonstrating high labeling efficiency and stability without compromising cell viability or function. This positions Superbranche’s technology as a robust, scalable solution for precise cell tracking and therapeutic monitoring in clinical settings, paving the way for next-generation regenerative medicine, oncology  and cell therapy applications.​